SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$3.72B
This Quarter Return
+8.02%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.74B
AUM Growth
-$1.55B
(-36%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-63.35%
Top 10 Holdings %
Top 10 Hldgs %
17.93%
Holding
941
New
2
Increased
1
Reduced
412
Closed
307
Top Buys
| 1 |
Knife River
KNF
|
+$2.5M |
| 2 |
Baytex Energy
BTE
|
+$541K |
| 3 |
Bank of Montreal
BMO
|
+$33.3K |
Top Sells
| 1 |
Starbucks
SBUX
|
+$50.5M |
| 2 |
Ovintiv
OVV
|
+$43.5M |
| 3 |
Blackrock
BLK
|
+$38.2M |
| 4 |
Deere & Co
DE
|
+$34.1M |
| 5 |
Goldman Sachs
GS
|
+$33.7M |
Sector Composition
| 1 | Technology | 22.1% |
| 2 | Industrials | 13.52% |
| 3 | Financials | 13.46% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Materials | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Accuray
ARAY
$175M
| $113K | ﹤0.01% |
29,219
| – | – |
|
602
Eldorado Gold
EGO
$5.35B
| $111K | ﹤0.01% |
11,000
| – | – |
|
|
NGM
603
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $110K | ﹤0.01% |
42,353
| – | – |
|
604
Kearny Financial
KRNY
$414M
| $107K | ﹤0.01% |
15,222
-1,888
| -11% | -$13.3K |
|
605
Caribou Biosciences
CRBU
$169M
| $105K | ﹤0.01% |
24,752
-18,627
| -43% | -$79.2K |
|
606
DHI Group
DHX
$143M
| $102K | ﹤0.01% |
26,549
-32,403
| -55% | -$124K |
|
607
Evolution Petroleum
EPM
$177M
| $101K | ﹤0.01% |
12,549
| – | – |
|
608
Champions Oncology
CSBR
$93.8M
| $97.2K | ﹤0.01% |
15,449
-5,170
| -25% | -$32.5K |
|
609
TherapeuticsMD
TXMD
$12.5M
| $97.1K | ﹤0.01% |
23,573
-14,469
| -38% | -$59.6K |
|
610
Nine Energy Service
NINE
$28.5M
| $96.1K | ﹤0.01% |
25,084
-47,649
| -66% | -$182K |
|
611
Nektar Therapeutics
NKTR
$843M
| $88.5K | ﹤0.01% |
10,252
| – | – |
|
|
OPI
612
Office Properties Income Trust
OPI
$17.4M
| $81.5K | ﹤0.01% |
10,582
-13,321
| -56% | -$103K |
|
613
Western New England Bancorp
WNEB
$251M
| $76.7K | ﹤0.01% |
13,136
-33,341
| -72% | -$195K |
|
614
Fulcrum Therapeutics
FULC
$393M
| $74.6K | ﹤0.01% |
22,594
-18,940
| -46% | -$62.5K |
|
|
NVTA
615
DELISTED
Invitae Corporation
NVTA
| $72.5K | ﹤0.01% |
64,200
| – | – |
|
616
SIGA Technologies
SIGA
$620M
| $67K | ﹤0.01% |
13,262
-23,397
| -64% | -$118K |
|
|
TCS
617
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $63.8K | ﹤0.01% |
1,355
-251
| -16% | -$11.8K |
|
|
GRTS
618
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $59.6K | ﹤0.01% |
30,547
| – | – |
|
619
Esperion Therapeutics
ESPR
$506M
| $58.1K | ﹤0.01% |
41,809
| – | – |
|
620
Amneal Pharmaceuticals
AMRX
$3.06B
| $52.9K | ﹤0.01% |
17,064
-42,400
| -71% | -$131K |
|
621
GrafTech
EAF
$229M
| $52.5K | ﹤0.01% |
1,042
-3,737
| -78% | -$188K |
|
622
ADMA Biologics
ADMA
$3.92B
| $49.1K | ﹤0.01% |
13,310
| – | – |
|
623
C4 Therapeutics
CCCC
$193M
| $48.3K | ﹤0.01% |
17,572
| – | – |
|
624
Barnes & Noble Education
BNED
$294M
| $46.1K | ﹤0.01% |
366
-584
| -61% | -$73.6K |
|
625
Polar Power
POLA
$6.05M
| $45.5K | ﹤0.01% |
4,961
-1,115
| -18% | -$10.2K |
|